Effect of CPAP Treatment on the Elderly With Mild to Moderate Sleep Apnea
Effect of CPAP Treatment on the Elderly With Mild to Moderate Sleep Apnea
Objective: To analyze the impact of CPAP treatment on cognitive, clinical and quality of life
 domains in patients over 70 years of age with mild-to-moderate OSA

 Primary Outcome: Epworth scale and QSQ domains

 Secondary Outcomes: Neurocognitive variables and CPAP adherence
Inclusion Criteria:

 -  Age equal or greater than 70 years of both sexes

 -  Patients with sleep study results with AHI ≥ 15 and < 30

 Exclusion Criteria:

 -  Alternative diagnoses of other non-respiratory sleep disorders that are also cause of
 pathological somnolence (eg, sdr restless legs, narcolepsy, etc.)

 -  Don't sign informed consent

 -  Acute or chronic respiratory insufficiency requiring home oxygen therapy

 -  Patients with Obesity Hypoventilation Syndrome

 -  Diagnosis of neuro-psychiatric diseases with the exception of anxiety - depression or
 diagnosis of dementia.

 -  Diseases of any origin in the acute phase

 -  Heart failure or recent stroke (less than 3 months).

 -  Central SAHS (more than 50% of the registry with central apneas or Cheyne-Stokes
 breathing)

 -  Pre-treatment with CPAP

 -  Inability to perform the diagnostic study of sleep due to the patient's condition

 -  Hipersomniaincapacitante (Epworth≥18) with no known or most likely cause related to
 SAHS